Home Cart 0 Sign in  

[ CAS No. 446292-08-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 446292-08-6
Chemical Structure| 446292-08-6
Structure of 446292-08-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 446292-08-6 ]

Related Doc. of [ 446292-08-6 ]

Alternatived Products of [ 446292-08-6 ]

Product Details of [ 446292-08-6 ]

CAS No. :446292-08-6 MDL No. :MFCD11977665
Formula : C22H19N3O6 Boiling Point : -
Linear Structure Formula :- InChI Key :KUQNYAUTIWQAKY-MRXNPFEDSA-N
M.W : 421.40 Pubchem ID :11690317
Synonyms :

Safety of [ 446292-08-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 446292-08-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 446292-08-6 ]
  • Downstream synthetic route of [ 446292-08-6 ]

[ 446292-08-6 ] Synthesis Path-Upstream   1~32

  • 1
  • [ 1325210-64-7 ]
  • [ 161596-47-0 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
95.5% at 120℃; for 4 h; ((S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione (4.56g, 22.46mmol, 1.3eq.) and 4-(4-isocyanatophenyl)morpholin-3-one (3.77g, 17.29mmol) were dissolved in isoamyl acetate (70mL) respectively, and heated to 120°C. Then magnesium chloride (0.12g, 1.28mmol) was added, the mixture was reacted for 4h, white solid was obtained by filtration (6.97g, yield:95.5percent). ESI-MS(m/z): 422(M+H), 444(M+Na); 1HNMR(400MHz, CDCl3) δ: 3.74(m, 2H), 3.94(m, 4H), 4.10(m, 2H), 4.32(s, 2H), 4.98(m, 1H), 7.34(d, 2H), 7.56(d, 2H), 7.75(m, 2H), 7.88(m, 2H); HPLC: 98.82percent
94.09% With lithium iodide In chlorobenzene at 115℃; for 4 h; [0048] (S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione (3.87 g, 19.06 mmol, 1.1 eq.) and 4-(4-isocyanatophenyl)morpholin-3-one (3.77 g, 17.29 mmol) were dissolved in chlorobenzene (70 mL) respectively, then heated to 115° C. and lithium iodide (0.23 g, 1.72 mmol) was added. The mixture was reacted for 4 h, white solid was obtained by filtration (6.85 g, yield: 94.09percent). [0049] ESI-MS (m/z): 422 (M+H), 444 (M+Na); [0050] 1HNMR (400 MHz, CDCl3) δ: 3.74 (m, 2H), 3.94 (m, 4H), 4.10 (m, 2H), 4.32 (s, 2H), 4.98 (m, 1H), 7.34 (d, 2H), 7.56 (d, 2H), 7.75 (m, 2H), 7.88 (m, 2H); [0051] HPLC: 98.91percent.
Reference: [1] Patent: EP2837628, 2015, A1, . Location in patent: Paragraph 0029
[2] Patent: US2015/38704, 2015, A1, . Location in patent: Paragraph 0048-0051
  • 2
  • [ 446292-07-5 ]
  • [ 32315-10-9 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
97.9% at 50 - 64℃; for 1 h; A compound having the structure of formula (I) (106.76 g, 270 mmol) was suspended in 4000 ml of anhydrous tetrahydrofuran(About 40ml / g), stir, gradually heated to 50 ° C, maintained at 50 ° C,A solution of triphosgene (80.2 g, 270 mmol) in tetrahydrofuran (268 ml) was added dropwise over 30 minutes,Heated to 64 ° C reflux, about 10 minutes after the clarification, about 1 hour and precipitation of solid, let cool to room temperature,The filter cake was washed with absolute ethanol (120 ml * 3 times) and air dried at 45 ° C to give 111.4 g of a compound having the structure of formula (II) in a yield of 97.9percent
89% With triethylamine In dichloromethane at 0 - 10℃; Amino alcohol 170 gm, 0.4293 moles and Triethylamine 41 14.72 gms, 0.9459 moles, was charged to Dichloromethane 2380 ml and cooled reaction mass to 0°C - 5°C. To the cooled reaction mass added triphosgene solution, 51.09 gms in 340 ml MDC, 0.18 moles drop wise at 5°C - 10°C in 60 min, and stirred for 60 - 90 min. Reaction mass quenched with water and distilled out MDC layer atmospherically till thick solid mass obtained. To the thick solid, charged tetrahydrofuran 1360 ml, distilled out 130 ml under vacuum. Cooled slurred mass to 25°C -30°C, stirred for 30 min, filtered. Wet material dried at 55°C -60°C to afford 162 gm dry material. Yield- 89percent
Reference: [1] Patent: CN104016975, 2017, B, . Location in patent: Paragraph 0098-0101
[2] Patent: WO2018/127762, 2018, A1, . Location in patent: Page/Page column 13
  • 3
  • [ 136918-14-4 ]
  • [ 1117893-60-3 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With triphenylphosphine In tetrahydrofuran at 20℃; for 0.0833333 h;
Stage #2: With di-isopropyl azodicarboxylate In tetrahydrofuran
To into a 250 ml three-necked round bottom flask was added (R) -4- [4- (5- hydroxymethyl-2-oxo - oxazole3-yl) - phenyl] - morpholin-3-one compounds (Formula II, 5 g, 17 1 mmol), tetrahydrofuran (75 ml), triphenyl.Phosphine (5. 38g, 20. 5mmol) and phthalimide (3. 02g, 20. 5mmol), the mixture was stirred at room temperature for 5 minutes.30 minutes slowly added isopropyl azodicarboxylate (4. 15g, 20. 5 mmol), continue stirring for 2 to 3 hours.Filtered and dried, to give the compound (Π1) 6. 7g, 93percent yield.
Reference: [1] Patent: CN105777734, 2016, A, . Location in patent: Paragraph 0014
  • 4
  • [ 634905-12-7 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
92.2% With copper(l) iodide; N,N-dimethyl-ethanamine; potassium carbonate In dichloromethane at 100℃; for 15 h; Sealed tube The reaction flask was charged with 49.5 g of the compound 4 (0.22 mol) obtained in Example 3-2, CuI (1.9 g, 10 mmol), N, N'-dimethylethylamine (30 mmol, 1.5 mL), potassium carbonate (0.5 mol) and 300 mL of dichloromethane, compound 5 (69.1 g, 0.2 mol) was added with stirring and the reaction flask was sealed and placed in an oil bath at 100 ° C for 15 hours. After the reaction was completed, the reaction solution was cooled to room temperature, the solvent was distilled off under reduced pressure, poured into 500 mL of water and extracted three times with ethyl acetate (3 x 500 mL). The combined organic layers were washed with saturated brine, dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated under reduced pressure to give a crude product which was recrystallized from ethyl acetate to give 77.7 g of compound 6 in a yield of 92.2percent and a purity of 99.6percent.
Reference: [1] Patent: CN105801572, 2016, A, . Location in patent: Paragraph 0073; 0074
  • 5
  • [ 446292-07-5 ]
  • [ 75-44-5 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
97.6% With <i>N</i>,<i>N</i>-dimethyl-aniline In chloroform at -20 - 10℃; for 10 h; Inert atmosphere Compound I was added to 39.5 g (0.1 mol), N,N-dimethylaniline 19.4 (0.16 mol), trichloromethane 120ml, added to 250ml of three bottles, stir to dissolve the solid. cooling to -20 °C, temperature control at -20°C ~ 10°C slowly into the phosgene about 10.9g (0.11mol), and then heat for 10h. Nitrogen was bubbled through for 15 minutes. The crude product of the compound of formula (II) was obtained by distilling off the trichloromethane under reduced pressure by heating under reduced pressure, Filtration and drying gave 41.1 g of the compound of formula (II) as a white solid in 97.6percent yield. HPLC, the purity was 98.95percent.
Reference: [1] Patent: CN106588905, 2017, A, . Location in patent: Paragraph 0074-0075
  • 6
  • [ 446292-07-5 ]
  • [ 530-62-1 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
97.9% at 19 - 60℃; for 1 h; Heating / reflux 2641 g of 2-((2R)-2-hydroxy-3-[4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-1H-isoindole-1,3(2H)-dione (V) are suspended in 22 l of toluene and, at 19° C., 1300 g of N,N-carbonyl-diimidazole are added.
The reaction mixture is subsequently heated under reflux for one hour and then, at 60° C., 4.5 l of ethanol are added.
After cooling to 25 to 30° C., the precipitated reaction product is filtered off with suction, washed with ethanol and then dried.
Yield: 2756 g; equivalent to 97.9percent of theory.
Melting point: 220.5° C.
93.55% at 25 - 30℃; for 8 h; In a four neck round bottom flask, charged dichloromethane (3400ml), 2-((2R)-2-Hydroxy-3- [4-(3-oxo-4-morpholinyl)phenyl]amino}propyl)-lH-isoindole-l,3(2H)-dione (340 g) and Ν,Ν' -dicarbonyldiimidazole (209.13 g) at 25 to 30°C. The obtained reaction mass then stirred for 8hr. at 25 to 30°C. Reaction mass is concentrated under reduced pressure to obtain residue. Added tetrahydrofuran (1700 ml) to residue. The obtained mixture is heated to 40 to 45°C for 30 minutes followed by cooling to room temperature. Finally obtained solid is filtered off and washed by tetrahydrofuran(170 ml) Yield =93.55percent
93.8% at 0 - 100℃; for 4 h; Large scale This example relates to the preparation of 2-{(S)-2-oxo-3-[4-(3-oxo- morpholine-4-yl)phenyl]-oxazolidine-5-yl-methyl}-isoindol-1 ,3-dione, step b) of the process. 17.0 kg of the compound (III) obtained in example 1 , 170 kg of chlorobenzene and 8.5 kg of Ν,Ν-carbonyldiimidazole are loaded into a reactor. The mass is brought to about 100 °C and maintained at this temperature for 4 hours. At the end of the reaction, the mass is cooled to 0-10 °C then filtered by washing it with 34.0 kg of chlorobenzene and lastly oven-dried. 17.0 kg of the desired compound (IV) are obtained, with a reaction yield equal to 93.8percent.
93.8% at 10 - 110℃; for 2 h; To a 2 litre 4 Neck RBF, charge Toluene (830 ml), Compound (IV) (100 gms). Stirr the reaction mass and cool to 10-15°C. Charge N,N-carbonyl-diimidazole (82 gms). Reflux the reaction mass at 105-110°C for 2 hrs. Cool the reaction mass to 55-60°C and charge methanol (170 ml). Cool the reaction mass further to 25-30°C and filter. Wash the residue with Methanol (50 gms). Dry the solid under vacuum. Dry Wt: 100 gms (Theoretical yield: 93.80percent); Purity: 99.78percent
90.73% for 4 h; Reflux 142.5 g (0.360 mol) of 2-((2R)-2-hydroxy-3-[4-(3-oxo-4-morpholinyl)phenyl]amino} propyl)-1 H-isoindole-1 , 3(2H)-dione (I), 175.32 g (1 .082 mol) of N,N- carbonyldiimidazole and 1425 mL of tetrahydrofuran were charged in a 3L flask and the reaction mass was heated to reflux for 4 hours. Then, the reaction mass was cooled down to 0 °C for 1 hour and the resulting solid was filtered off and dried under vacuum at 70 °C.Yield: 137.8 g. Molar yield: 90.73percent. HPLC purity: 99.74percent. M.P.: 223 °C. S.O.R.: [a ]D25 = -75.26° (c = 1 ,DMSO)
88.3% for 3 h; Industry scale; Reflux N,N-Carbonyldiimidazole (2.897kg , 1.47eq) was added to a suspension of compound according to d. ) (5.1kg, 12.114mol ) in toluene (49L) . The reaction mixture was refluxed for 3h, then at 60 0C, ethanol (14L) was added. After cooling to 25 0C, the precipitate was filtered and 4.8 kg of (S) -2- ( (2-oxo-3- (4- (3- oxomorpholino) phenyl) oxazolidin-5-yl) methyl) isoindoline- 1, 3-dione was obtained as a colorless solid (Yield 88,3 percent)
88.2% With potassium carbonate In dichloromethane at 20℃; for 5 h; To suspension of 2-[(2R)-2-hydroxy-3-[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl]-1H-isoindole-1,3(2H)-dione (170 gm) and potassium carbonate (59.3 gm) in dichloromethane (1500 ml) was added 1,1’-carbonylbis(1H-imidazole) (153.4 gm) at room temperature. Reaction mass was then stirred for 5 hr at room temperature. After completion of reaction, inorganic base is removed by filtration. The obtained filtrate is concentrated under reduced pressure to yield solid. To this solid tetrahydrofuran (850 ml) was added followed by stirring and filtration. The obtained solid is dried under vacuum for 4 hr at 50 °C to obtain 2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione. [Yield = 160 gm (88.2 percent); Purity (HPLC) =99.65 percent]
88.2% With potassium carbonate In dichloromethane at 20℃; for 5 h; To suspension of 2-[(2R)-2-hydroxy-3-[4-(3-oxomorpholin-4-yl)phenyl]amino}propyl]-1H-isoindole-1,3(2H)-dione (170 gm) and potassium carbonate (59.3 gm) in dichloromethane (1500 ml) was added 1,1'-carbonylbis(1H-imidazole) (153.4 gm) at room temperature.
Reaction mass was then stirred for 5 hr at room temperature.
After completion of reaction, inorganic base is removed by filtration.
The obtained filtrate is concentrated under reduced pressure to yield solid.
To this solid tetrahydrofuran (850 ml) was added followed by stirring and filtration.
The obtained solid is dried under vacuum for 4 hr at 50° C. to obtain 2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione. [Yield=160 gm (88.2percent); Purity (HPLC)=99.65percent]
85% for 5 h; Reflux Example 1 : Preparation of 2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-l,3-oxazolidin- 5-yl}methyl)-lH-isoindol-l,3(2H)-dione, the compound of formula I(2R)-2-Hydro y-3-[4-(3-oxo-4-moφholinyl)phenyl]amino-propyl-lH-isoindol-l ,3(2H)- dione (10.0 g; 25 mmol), the compound of formula III, containing 1.0 percent of the (2S)-isomer was charged into a flask and tetrahydrofuran (200 ml) was added. NN-carbonyldiimidazole (4.1 g; 25 mmol) was added to the stirred mixture. The mixture was heated up to boil and refluxed for 5 hours.The white suspension was cooled to the temperature of 20°C, stirred for 1.5 hours, aspirated and washed with tetrahydrofuran (50 ml). The product was poured into a flask with 2- methoxyethanol (175 ml). The mixture was heated up to boil and stirred until dissolution. Active carbon (0.5 g) was added to the solution and filtered off while hot after 10 minutes and washed with 2-methoxyethanol (10 ml). The solution was cooled to the laboratory temperature and stirred for 1 hour. The resulting crystals were aspirated and washed with methanol (100 ml). The aspirated product was dried in a vacuum drier at a temperature up to 60°C. 9 g (85 percent of theory) of 2-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-l ,3-oxazolidin-5-yl} methyl)- lH-isoindol- l ,3(2H)-dione with the isomeric purity of 99.98percent were obtained, HPLC purity 99.7percent, m. p. = 221 - 223 °C. The polymorphous structure of the compound (I) was also characterized with the X-ray powder diffraction (Fig. 1) with the characteristic 2 theta angles 4.63; 12.00; 13.9; 15.3; 15.87 and 24.55.
73% With dmap In tetrahydrofuran for 21 h; Reflux; Industrial scale 300 ml of THF were added to 20 g of 2-((2i?)-2-hydroxy-3-{ [4-(3-oxomorpholin-4- yl)phenyl]amino}propyl)- lH-isoindol-l ,3(2H)-dione (14, 0.0506 mol), 16 g of Ι , Γ- carbonyldiimidazole (0.09869 mol) and 0.1 g of 4-dimethylamino)pyridine. The suspension was stirred and heated to boiling for 7 hours, then slightly cooled and another portion of Ι , Γ-carbonyldiimidazole (0,09869 mol) was added. Then, the suspension was stirred under boiling for 14 hours. After that the mixture was cooled to 25°C, which was followed by filtration, washing of the cake with THF, with an ethanol/water mixture (9: 1) and drying. 15.6kg of an off-white powder was obtained that melted at the temperature of 216 to 217°C; HPLC 99.9percent, content of the (R)- isomer below 0.03percent, yield 73percent.
95 g at 80 - 85℃; for 6 h; 100 gm (0.2531 moles) 2-((2R)-2-Hydroxy-3-[4-(3-oxo-4-morpholinyl) phenyl] amino} propyl) -lH-isoindole- 1, 3(2H)-dione (V) is added in 700 ml Dimethyl carbonate, 69.9 gm0 (0.4301 moles) Carbonyl diimidazole and 15.4 gm (0.1260 moles) Dimethylaminopyridine. Reaction mass is heated to 80-85°C for 6 hours. It is then cooled, chilled and filtered to get 2-({(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]- l,3- oxazolidiii-5-yl}methyl)- lH-isoindole- l,3(2H)-dione. it is washed with dimethyl carbonate followed by water. Wet Wt = 95 gm

Reference: [1] Patent: US2005/182055, 2005, A1, . Location in patent: Page/Page column 1; 3
[2] Patent: WO2014/102820, 2014, A2, . Location in patent: Paragraph 058
[3] Patent: WO2015/198259, 2015, A1, . Location in patent: Page/Page column 6
[4] Patent: WO2016/199027, 2016, A1, . Location in patent: Page/Page column 18-19
[5] Patent: WO2013/53739, 2013, A1, . Location in patent: Page/Page column 31
[6] Patent: WO2011/12321, 2011, A1, . Location in patent: Page/Page column 31
[7] Patent: WO2013/121436, 2013, A2, . Location in patent: Page/Page column 26; 27
[8] Patent: US2015/11756, 2015, A1, . Location in patent: Paragraph 0118
[9] Journal of Medicinal Chemistry, 2005, vol. 48, # 19, p. 5900 - 5908
[10] Patent: WO2012/41263, 2012, A2, . Location in patent: Page/Page column 9
[11] Patent: WO2013/120464, 2013, A1, . Location in patent: Page/Page column 8-9
[12] Patent: WO2012/32533, 2012, A2, . Location in patent: Page/Page column 15-16
[13] Patent: WO2013/98833, 2013, A2, . Location in patent: Page/Page column 41-42
[14] Patent: US2014/378682, 2014, A1, . Location in patent: Paragraph 0211; 0212
[15] Patent: WO2016/30669, 2016, A1, . Location in patent: Page/Page column 28; 29
  • 7
  • [ 51594-55-9 ]
  • [ 1074-82-4 ]
  • [ 79-22-1 ]
  • [ 438056-69-0 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: at 20℃; Cooling
Stage #2: With sodium hydrogencarbonate In butan-1-ol at 0 - 5℃;
Stage #3: at 95 - 100℃; for 3 h;
4-(4-Aminophenyl)morpholin-3-one (100 gm) was added in n-butanol (300 ml) and charged Alumia sulfonic acid at ambient temperature. Cool the mass, added (R)-Epichlorohydrin (72 gm) and maintain the reaction mass at below 20°C. Confirmed the completion of reaction, separated the catalyst. Added sodiumbicarbonate, cool the mass temperature to Q-5°C and added methylchloroformate (56 gm) . After completion of reaction, evaporated the n- butanol and charged N,N-dimethylformamide (500 mi), potassium phthalimide (122 gm). The reaction temperature maintained at 95- 100°C for 3 hours. Cool the mass temperature to ambient temperature, quenched the mass into water. Filtered the mass and washed the product with water. Dried the material up to get constant weight. The obtained 2-({(5Sj-2-Qxo-3-[4-(3-Gxo-4- morpholmyl]phenyl ]-- 1 ,3--oxazol.idm-5--yl}methyl)-- 1 H--isoindole-- 1 ,3(2H)--d.ione was 186 gm (85percent yield) .
Reference: [1] Patent: WO2018/55499, 2018, A1, . Location in patent: Page/Page column 12
  • 8
  • [ 1450876-94-4 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
78% With potassium <i>tert</i>-butylate In tetrahydrofuran for 19 h; Reflux 25 g of 2-((2i?)-2-hydroxy-3-(N-(4-(3-oxomorpholin-4-yl)phenyl)-lH-imidazol-yl-l - carboxamido)propyl)- lH-isoindol-l ,3(2H)-dione (16, 51 mmol) prepared according to Example 4 were suspended in 350 ml of THF, 5.5 ml of a solution of tert-BuOK (20percent by weight, 9.1 mmol) was added dropwise under stirring, which was diluted with 20 ml of THF before adding. The suspension was stirred and heated to boiling for 19 hours, then 400 ml of ethanol were added and the boiling continued for 2 hours. Cooling of the mixture to 35°C was followed by filtration, washing of the cake with ethanol, water and ethanol again. After drying, 16.8 g of an off-white powder that melted at 215-217°C was obtained; HPLC 99.8percent, content of the (R isomer below 0.03percent, yield 78percent, see Fig. 4.
Reference: [1] Patent: WO2013/120464, 2013, A1, . Location in patent: Page/Page column 11-12
  • 9
  • [ 446292-07-5 ]
  • [ 24424-99-5 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
93.2% With sodium hydride In toluene for 48 h; Reflux 60 g (0.25 mol) of compound 6 and 400 mL of toluene were charged into a 500 mL dry three-necked flask, stirred(0.3 mol) of di-tert-butyl dicarbonate (Boc anhydride) and 0.6 g of sodium hydride were added and the system was refluxed for 48 h. TLC was detected until the reaction was complete and the partial solvent was distilled off to give 47.4 g of the white crystals of Compound 7 (93.2percent)
Reference: [1] Patent: CN103951661, 2017, B, . Location in patent: Paragraph 0045
  • 10
  • [ 136918-14-4 ]
  • [ 1424942-80-2 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2013/98833, 2013, A2, . Location in patent: Page/Page column 39
[2] Patent: US2014/378682, 2014, A1, . Location in patent: Paragraph 0200; 0201
  • 11
  • [ 1429334-03-1 ]
  • [ 438056-69-0 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
0.5 g With N-benzyl-N,N,N-triethylammonium chloride; potassium carbonate In N,N-dimethyl-formamide at 80℃; for 18 h; To a suspension of (S)-l-phthalimido-2-((phenyloxycarbonyl) oxy)-3-propylchloride (3.595g, 10 mmol) (prepared in Step- I ) and 4-(4-aminophenyl)morpholin-3-one (2.4g, 12.5 mmol, 1.25 eq) in DMF ( 20 ml). Potassium carbonate ( 3.45 gms, 25 mmol, 2.5 eq) and catalytic amount of triethylbenzyl ammonium chloride were added and then stirred for about 18 hrs at 80°C .The reaction mix. is poured into the water ( 50 ml) and then extracted with the DCM ( 25 ml x 3). The combined organics are washed with Dil.HCl (10 ml x2) and water ( 10 ml x 2). Distill off the solvent under reduced pressure to yield a title compound.( (Yield = 0.5 g, 12 percent of the theory).
Reference: [1] Patent: WO2013/46211, 2013, A1, . Location in patent: Page/Page column 71; 72
  • 12
  • [ 1313613-18-1 ]
  • [ 148857-42-5 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
2 g With lithium tert-butoxide In tetrahydrofuran; N,N-dimethyl-formamide at 20℃; for 44 h; Cooling with ice To a solution of [4-(3-oxo-moφholin-4-yl)phenyl]carbamic acid benzyl ester ( 3.26 g, 10 mmol) and (S)-l-phthalimido-3-chloro-propan-2-ol( 3.02 g, 1.26 eq) ( prepared as per US6,362,334B1) in DMF ( 10 ml) in an ice-bath was added a solution of Lithium-t-Butoxide ( 1.956 g, 2.4 eq) in THF ( 15 ml) . The resultant solution was allowed to stand at 20° C for 44 hrs. Sat. aq. ammo, chloride ( 25 ml) , water ( 30 ml) and DCM ( 50 ml) was added and the phases are separated . The organics dried on MgS04 and distill off the solvent completely to yield title compound as a off- white crystalline solid. Re-crystallized from acetone to yield a title compound as a white crystalline solid. (Yield = 2.0 g, 48 percent of the theory).
Reference: [1] Patent: WO2013/46211, 2013, A1, . Location in patent: Page/Page column 70; 71
  • 13
  • [ 1313613-18-1 ]
  • [ 446292-08-6 ]
YieldReaction ConditionsOperation in experiment
0.92 g With lithium tert-butoxide In tetrahydrofuran; methanol; N,N-dimethyl-formamide at 5 - 24℃; for 21 h; To a solution of [4-(3-oxo-morpholin-4-yl)phenyl]carbamic acid benzyl ester ( 3.26 g, lmmol) in DMF ( 10 ml) and methanol ( 0.64 g, 20 mmol) at 20 ° C is added a solution of Lithium-t-butoxide ( 2.4 g, 30 mmol, 3eq) in THF ( 15 ml) while keeping less than 24°C with an ice-bath . The solution is cooled to 5°C, (S)-2-phthalimido-l-(chloromethyl) ethylacetate (5.63 g,2eq) (prepared in step I) solution is added. The resulting solution is allowed to stand at 21 ° C for 21 hrs. Sat. aq.NCl ( 25 ml),water ( 30 ml) , Sat. NaCl( 25 ml) and DCM ( 50 ml) were added and the phases are separated and the aq. washed with DCM( 20 ml x3 ) . The organics are dried on MgS04 and concentrated to get crude compound .Re-crystallize from acetone to yield a title compound as a white - crystalline solid (Yield= 0.92 g, 22 percent of the theory).
Reference: [1] Patent: WO2013/46211, 2013, A1, . Location in patent: Page/Page column 70
  • 14
  • [ 438056-69-0 ]
  • [ 446292-08-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 19, p. 5900 - 5908
[2] Patent: WO2011/12321, 2011, A1,
[3] Patent: WO2012/32533, 2012, A2,
[4] Patent: WO2012/32533, 2012, A2,
[5] Patent: WO2012/32533, 2012, A2,
[6] Patent: WO2012/32533, 2012, A2,
[7] Patent: WO2013/53739, 2013, A1,
[8] Patent: WO2013/98833, 2013, A2,
[9] Patent: WO2013/46211, 2013, A1,
[10] Patent: WO2013/46211, 2013, A1,
[11] Patent: US2014/378682, 2014, A1,
[12] Patent: US2015/38704, 2015, A1,
[13] Patent: EP2837628, 2015, A1,
[14] Patent: WO2016/30669, 2016, A1,
[15] Patent: CN105085370, 2017, B,
[16] Patent: CN105085431, 2017, B,
[17] Patent: CN105085371, 2017, B,
[18] Patent: CN103951661, 2017, B,
[19] Patent: CN106588905, 2017, A,
[20] Patent: CN105085508, 2017, B,
[21] Patent: CN105085507, 2017, B,
  • 15
  • [ 446292-07-5 ]
  • [ 530-62-1 ]
  • [ 446292-08-6 ]
  • [ 1450876-94-4 ]
Reference: [1] Patent: WO2013/120464, 2013, A1, . Location in patent: Page/Page column 11
  • 16
  • [ 446292-04-2 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2011/12321, 2011, A1,
[2] Patent: WO2013/98833, 2013, A2,
[3] Patent: WO2013/98833, 2013, A2,
[4] Patent: US2014/378682, 2014, A1,
[5] Patent: US2014/378682, 2014, A1,
[6] Patent: WO2016/30669, 2016, A1,
  • 17
  • [ 122-98-5 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2011/12321, 2011, A1,
[2] Patent: WO2013/98833, 2013, A2,
[3] Patent: WO2013/98833, 2013, A2,
[4] Patent: US2014/378682, 2014, A1,
[5] Patent: US2014/378682, 2014, A1,
  • 18
  • [ 29518-11-4 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2011/12321, 2011, A1,
[2] Patent: WO2013/98833, 2013, A2,
[3] Patent: WO2013/98833, 2013, A2,
[4] Patent: US2014/378682, 2014, A1,
[5] Patent: US2014/378682, 2014, A1,
  • 19
  • [ 161596-47-0 ]
  • [ 446292-08-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 19, p. 5900 - 5908
[2] Patent: WO2013/53739, 2013, A1,
[3] Patent: CN106588905, 2017, A,
  • 20
  • [ 446292-07-5 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2005/68456, 2005, A1, . Location in patent: Page/Page column 7
  • 21
  • [ 1252018-28-2 ]
  • [ 1074-82-4 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2012/32533, 2012, A2, . Location in patent: Page/Page column 14
  • 22
  • [ 161596-47-0 ]
  • [ 438056-69-0 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2013/98833, 2013, A2,
[2] Patent: WO2013/121436, 2013, A2,
[3] Patent: US2015/11756, 2015, A1,
[4] Patent: WO2014/102820, 2014, A2,
[5] Patent: US2014/378682, 2014, A1,
[6] Patent: WO2015/198259, 2015, A1,
[7] Patent: WO2016/199027, 2016, A1,
[8] Patent: WO2018/127762, 2018, A1,
  • 23
  • [ 1252018-10-2 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2012/32533, 2012, A2,
[2] Patent: WO2012/32533, 2012, A2,
[3] Patent: WO2012/32533, 2012, A2,
[4] Patent: CN103951661, 2017, B,
  • 24
  • [ 1446022-14-5 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2013/98833, 2013, A2,
[2] Patent: US2014/378682, 2014, A1,
  • 25
  • [ 1446022-15-6 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2013/98833, 2013, A2,
[2] Patent: US2014/378682, 2014, A1,
  • 26
  • [ 1117893-60-3 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2013/98833, 2013, A2,
[2] Patent: US2014/378682, 2014, A1,
  • 27
  • [ 148857-42-5 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2013/46211, 2013, A1,
[2] Patent: WO2013/46211, 2013, A1,
  • 28
  • [ 136918-14-4 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2012/41263, 2012, A2,
  • 29
  • [ 446292-07-5 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2013/120464, 2013, A1,
  • 30
  • [ 1074-82-4 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: CN105801572, 2016, A,
  • 31
  • [ 929281-94-7 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: CN105801572, 2016, A,
  • 32
  • [ 446292-08-6 ]
  • [ 898543-06-1 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With methylamine In methanol; water at 25 - 65℃; for 5 h;
Stage #2: With hydrogenchloride In methanol; water at 25 - 30℃; for 0.5 h;
In a four neck round bottom flask, charged methanol (2900 ml), 2-([(5S)-2- Oxo-3-[4-(3-oxo- 4-morpholinyl)phenyl]-l,3-oxazolidin-5-yl}methyl)-lH-isoindole-l,3(2H)-dione (290 g), and 40percent aqueous methylamine (265 g) at 25 to 30°C. Reaction mass is stirred for 1 h at 25 to 30°C and then heated to 60 to 65°C, and maintained at same temperature for 4 h. Reaction mixture then cooled to 25 to 30°C and added cone, hydrochloric acid (290 ml, pH should be 1 to 2) and stirred for 30 minutes. Obtained solid is filtered off and washed by chilled methanol (290ml). Yield= 92.0percent
89.7%
Stage #1: With methylamine In ethanol; water at 40 - 60℃; for 8 h;
Stage #2: With hydrogenchloride In water at 15℃; for 2 h;
The reaction flask was charged with 210.7 g (0.5 mol) of the compound prepared in Example 7,(S) -2- [2-oxo-3- (4- (3-oxorpholine) phenyl) oxazolidin-5-yl] methyl} isoindole- VII),1500ml of anhydrous ethanol, 500ml of 30percent aqueous solution of methylamine, stirring evenly,The temperature was raised to 40 ° C to 60 ° C for 8 hours,TLC in the control (dichloromethane: methanol = 20: 1, volume ratio) reaction is complete,With 10percent hydrochloric acid to adjust the pH to 1-2 between the precipitation of a large number of white solid, cooling to about 15 ° C,Stirring for 2 hours, filtering, filter cake with 300ml anhydrous ethanol washing, vacuum drying,A mixture of 147.0 g of the white solid (compound of formula VIII) was obtained in a molar yield of 89.7percent, and 1 ^ (purity: 98.7percent).
89.7%
Stage #1: With methylamine In ethanol; water at 40 - 60℃; for 8 h;
Stage #2: With hydrogenchloride In ethanol; water at 15℃; for 2 h;
210.7 g (0.5 mol) of (S)-2-[2-oxo-3-(4-(3-oxomorpholine)benzene] prepared in Example 7 was added to the reaction flask.Based on oxazolidine-5-yl]methyl}isoindole-1,3-dione (formula VII), 1500 ml of anhydrous ethanol,500 ml of a 30percent aqueous solution of methylamine was stirred and heated to 40°C to 60°C for 8 hours.TLC control (dichloromethane:methanol = 20:1, volume ratio) reaction is complete, with 10percent hydrochloric acid to adjust the pH to between 1-2, precipitated a lot of white solids, cooled to about 15 °C, stirred for 2 hours, filtered The filter cake was washed with 300 ml of anhydrous ethanol and dried under reduced pressure to obtain 147.0 g of a white solid (compound of formula VIII) with a molar yield of 89.7percent and an HPLC purity of 98.7percent.
86.5%
Stage #1: With methylamine In ethanol; water at 60 - 63℃; for 2 h;
Stage #2: With hydrogenchloride In ethanol; water at 55 - 60℃;
Reference example 3: Synthesis of (S)-4-{4-[5-(aminomethyl)-2-oxo-l,3-oxazolidin- 3-yl]phenyl}morpholin-3-one hydrochloride (compound IV-hydrochloride)26.00 g (79.3 mmol) of (5)-2-({2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-l,3- oxazolidin-5-yl}methyl)-lH-isoindole-l,3(2H)-dione (compound III, obtained from compound II following the process disclosed in the ' 823 patent) were suspended in 95.0 mL of ethanol. 21.1 mL (271.6 mmol) of 40percent w/w aqueous methylamine were added to the suspension, and the resulting mixture was heated to 60-63 °C and maintained at this temperature for about 2 hours. The content of unreacted compound III was checked to be below 5percent by TLC. After cooling to 55-60 °C, a total of 31.45 g (172.3 mmol) of 20percent w/w aqueous hydrochloric acid were added over the reaction mixture until the pH was 2.65. Precipitation was observed during the addition. The resulting suspension was cooled down to 20 °C and subsequently filtered. The collected solid was washed with1 5.0 mL of methanol to give 20.01 g of wet (,S)-4-{4-[5-(aminomethyl)-2-oxo-l,3- oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride as a white solid. After drying at 60 °C, 17.49 g of dry product were obtained. Yield: 86.5percent.
80%
Stage #1: With methylamine In methanol at 25℃; for 6 h; Reflux
Stage #2: With hydrogenchloride In methanol; water at 25 - 30℃; for 1 h;
Methyl amine (40 percent strength, 153.2 ml) is added to suspension of 2- ({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione (150 gm) in methanol (1500 ml) at 25 to 30 °C. The reaction mass was then refluxed for 6 hr. After completion of reaction, the reaction mass was cooled to 25-30 °C, the pH of reaction mass was adjusted to 2-3 using cone. HCl. Reaction mass was stirred for 1 hr & filtered off the solid. The solid obtained was washed with methanol (50 ml) Obtained solid was dissolved in mixture of methanol (500 ml) and methylene dichloride (750 ml) by adjusting pH of reaction mass to 7-8 using triethylamine at 25-30 °C and stirred till clear solution was obtained, pH of reaction mass was adjusted to 4-5 by using acetic acid at 25-30 °C. Reaction mass was stirred for 1 h at 25-30 °C and filtered off the solid. The solid obtained was washed with methanol (50 ml) and dried under vacuum at 50 to 55 °C for 5 hr to obtain 4-{4-[(5S)-5-(aminomethyl)-2-oxo- 1 ,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride. [Yield = 92.4 gm (80 percent); Purity (HPLC) = 98.0 percent]
80%
Stage #1: With methylamine In methanol at 25℃; for 6 h; Reflux
Stage #2: With hydrogenchloride In methanol; water at 25 - 30℃; for 1 h;
Methylamine (40percent strength, 153.2 ml) was added to suspension of 2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)-1H-isoindole-1,3(2H)-dione (150 gm) in methanol (1500 ml) at 25 to 30° C.
The reaction mass was refluxed for 6 hr, cooled to 25-30° C., followed by slow addition of acetic acid (300 ml) reaction mass.
Thereaction mass was stirred for 30 min at 25-30° C. pH of the reaction mass was adjusted to 2-3 using conc. HCl.
Reaction mass was stirred for 1 hr & filtered off the solid.
The solid obtained was washed with methanol (50 ml)
Obtained solid dissolved in mixture of methanol (500 ml) and methylene dichloride (750 ml) by adjusting pH of reaction mass to 7-8 using triethylamine at 25-30° C. and stirred till clear solution was obtained, then adjusted the pH of reaction mass to 4-5 by using acetic acid at 25-30° C.
Reaction mass was stirred for 1 h at 25-30° C. and filtered off the solid.
The solid obtained was washed with methanol (50 ml) and dried under vacuum at 50 to 55° C. for 5 hr to obtain 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one hydrochloride.
[Yield=92.4 gm (80percent); Purity (HPLC)=98.0percent]
80.5%
Stage #1: With methylamine In ethanol; water at 55 - 63℃; for 2 h;
Stage #2: With hydrogenchloride In ethanol; water
2 - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5- yl} methyl) -1,3 (2H) -dione (Formula 5) Were suspended in 150 ml of ethanol at 22 °C ,16.2 g of a methylamine solution (concentration in water of 40percent) was added.The reaction mixture is then heated to 60-63 °C,The resulting solution was stirred at this temperature for 2 hours.55 ° C to 60 ° C After cooling,A total of 33.5 g of a hydrochloric acid solution (20percent in water concentration) was added until the pH reached 2.7.After confirming that the crystallization of the product has commenced, After cooling,The precipitated reaction product was filtered under suction, washed with methanol and then dried to give 12.5 g of the desired product. (Yield: 80.5percent)
147 g
Stage #1: With methylamine In ethanol; water at 40 - 60℃; for 8 h;
Stage #2: With hydrogenchloride In water at 15℃;
210.7 g (0.5 mol) of (S)-2-[2-oxo-3-(4-(3-oxomorpholine)phenyl]oxazolidine-5-yl] prepared in Example 7 was added to the reaction flask. Methyl isonon-1,3-dione (formula VII), 1500 ml of anhydrous ethanol, and 500 ml of a 30percent aqueous solution of methylamine were stirred well and heated to 40° C. to 60° C. for 8 hours. TLC control (2) Chloroethane:methanol = 20:1, volume ratio) The reaction is complete. Adjust the pH to between 1-2 with 10percent hydrochloric acid, precipitate a large amount of white solid, cool down to about 15°C, stir for 2 hours, filter and filter cake with 300ml The mixture was washed with anhydrous ethanol and dried under reduced pressure to obtain 147.0 g of a white solid (the compound of Formula VIII) in a molar yield of 89.7percent. The HPLC purity was 98.7percent.

Reference: [1] Patent: WO2014/102820, 2014, A2, . Location in patent: Paragraph 059
[2] Patent: CN105085371, 2017, B, . Location in patent: Paragraph 0102-0104
[3] Patent: CN105085431, 2017, B, . Location in patent: Paragraph 0093; 0094; 0095; 0096; 0097; 0098; 0099
[4] Patent: WO2012/35057, 2012, A2, . Location in patent: Page/Page column 29
[5] Patent: WO2013/121436, 2013, A2, . Location in patent: Page/Page column 27
[6] Patent: US2015/11756, 2015, A1, . Location in patent: Paragraph 0125; 0126; 0127
[7] Patent: KR2017/98031, 2017, A, . Location in patent: Paragraph 0058-0063
[8] Patent: WO2013/53739, 2013, A1, . Location in patent: Page/Page column 33
[9] Patent: CN105085507, 2017, B, . Location in patent: Paragraph 0116-0118; 0120; 0121
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 446292-08-6 ]

Rivaroxaban Related Intermediates

Chemical Structure| 161596-47-0

[ 161596-47-0 ]

(S)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione

Chemical Structure| 446292-07-5

[ 446292-07-5 ]

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione

Chemical Structure| 721401-53-2

[ 721401-53-2 ]

(R)-5-Chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide

Chemical Structure| 446292-10-0

[ 446292-10-0 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one

Chemical Structure| 438056-69-0

[ 438056-69-0 ]

4-(4-Aminophenyl)morpholin-3-one

Related Functional Groups of
[ 446292-08-6 ]

Aryls

Chemical Structure| 446292-10-0

[ 446292-10-0 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one

Similarity: 0.85

Chemical Structure| 446292-07-5

[ 446292-07-5 ]

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione

Similarity: 0.85

Chemical Structure| 898543-06-1

[ 898543-06-1 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride

Similarity: 0.84

Chemical Structure| 350684-49-0

[ 350684-49-0 ]

tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

Similarity: 0.74

Chemical Structure| 174855-57-3

[ 174855-57-3 ]

1-Boc-4-(2-Formylphenyl)piperazine

Similarity: 0.74

Amides

Chemical Structure| 446292-10-0

[ 446292-10-0 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one

Similarity: 0.85

Chemical Structure| 446292-07-5

[ 446292-07-5 ]

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione

Similarity: 0.85

Chemical Structure| 898543-06-1

[ 898543-06-1 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride

Similarity: 0.84

Chemical Structure| 350684-49-0

[ 350684-49-0 ]

tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

Similarity: 0.74

Chemical Structure| 174855-57-3

[ 174855-57-3 ]

1-Boc-4-(2-Formylphenyl)piperazine

Similarity: 0.74

Related Parent Nucleus of
[ 446292-08-6 ]

Morpholines

Chemical Structure| 446292-10-0

[ 446292-10-0 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one

Similarity: 0.85

Chemical Structure| 446292-07-5

[ 446292-07-5 ]

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione

Similarity: 0.85

Chemical Structure| 898543-06-1

[ 898543-06-1 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride

Similarity: 0.84

Chemical Structure| 51207-86-4

[ 51207-86-4 ]

(4-Aminophenyl)(morpholino)methanone

Similarity: 0.70

Chemical Structure| 183557-81-5

[ 183557-81-5 ]

3-Morpholinobenzamide

Similarity: 0.68

Indolines

Chemical Structure| 446292-07-5

[ 446292-07-5 ]

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione

Similarity: 0.85

Chemical Structure| 391668-75-0

[ 391668-75-0 ]

tert-Butyl 6-formylindoline-1-carboxylate

Similarity: 0.73

Chemical Structure| 129487-92-9

[ 129487-92-9 ]

tert-Butyl 5-aminoindoline-1-carboxylate

Similarity: 0.69

Chemical Structure| 871013-98-8

[ 871013-98-8 ]

tert-Butyl 4-aminoisoindoline-2-carboxylate

Similarity: 0.69

Chemical Structure| 252882-60-3

[ 252882-60-3 ]

1'-Boc-1,2-dihydro-2-oxo-spiro[3H-indole-3,4'-piperidine]

Similarity: 0.68

Oxazolidines

Chemical Structure| 446292-10-0

[ 446292-10-0 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one

Similarity: 0.85

Chemical Structure| 898543-06-1

[ 898543-06-1 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride

Similarity: 0.84

Chemical Structure| 167010-30-2

[ 167010-30-2 ]

(S)-N-((3-(3,5-Difluorophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide

Similarity: 0.69

Chemical Structure| 168828-90-8

[ 168828-90-8 ]

(S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one

Similarity: 0.68

Chemical Structure| 168828-82-8

[ 168828-82-8 ]

(5R)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-5-hydroxymethyl-2-oxazolidione

Similarity: 0.67